ჩვენი პროდუქტები
ყველა პროდუქტი
ალიმენტური ტრაქტი და მეტაბოლიზმი
სისტემური გამოყენების ინფექციის საწინააღმდეგო
ანტიპარაზიტული პროდუქტები
სისხლი და სისხლ-წარმომქმნელი ორგანოები
კარდიო-ვასკულური სისტემა
დერმატოლოგია
შარდ-სასქესო სისტემა
ძვალ-კუნთოვანი სისტემა
ნერვული სისტემა
სასუნთქი სისტემა
სამომავლოდ დაგეგმილი პროდუქტები
|
|
Cardiovascular System
Toxivenol (Injections / Tablets) (Troxerutin / Carbazochrome)
CONTENT:
Tablets. Tablet contains troxerutin 300 mg, carbazochrome 3.0 mg.
Ampoules. Ampoule contains troxerutin 150 mg, carbazochrome 1.5 mg.
PHARMACOTHERAPEUTIC GROUP:
Angioprotector. Agents, decreasing capillary permeability. Hemostatic agent.
PHARMACOLOGICAL PROPERTIES:
Optimal combination of components troxerutin and carbazochrome causes high
pharmacological efficacy of drug product, that enables to treat vascular
diseases and hemorrhage syndromes at capillary weakness. Troxerutin, known also
as vitamin P4, is a bioflavonoid, which increases vascular resistance (vascular
protecting action) and decreases permeability, preventing from excessive
penetration of blood liquids into tissues (antiedema and impermeability action).
Pharmacological effect causes increase of vitamin C activity, which protects
from permeability of membranes and augments hyaluronic acid production; it is a
mucopolysaccharide, responsible for density of vascular walls. Besides,
reduction in release of histamine, which is potent vasodilator and pro-edematous
agent, is observed.
Carbazochrome is an orthoquinone, adrenalin oxidation product without
sympathomimetic activity resulted from absence of secondary amine group and o-diphenol
group. Vasoconstrictive local influence on small vessels of bleeding zone
results in decrease of bleeding duration. This phenomenon occurs without
arterial pressure increase and changes of cardiac function. It was found, that
carbazochrome evidently influences capillary permeability and strength, tone and
contraction strength of vessels.
Solution for injection is used in urgent treatment and in case of necessity of
rapid therapeutic effect.
THERAPEUTIC INDICATIONS:
- chronic venous insufficiency, varix dilatation, surface trombophlebitis,
periphlebitis, posttraumatic edema, haematoma, trophic disturbances during
chronic venous insufficiency (dermatitis, trophic ulcer);
- hemorrhoidal bolus;
- diabetic angiopathy;
- retinopathy.
CONTRAINDICATIONS:
- Hypersensitivity to drug components.
SIDE EFFECTS:
It has good tolerability without any adverse effects.
DOSAGE AND ADMINISTRATION:
Dosage regimen and course of treatment are individual: 3-9 ml per day
intramuscularly, 2-4 tablets per day.
OVERDOSE:
There are no reported cases of accidental and deliberate drug overdose.
INTERACTION WITH DRUGS:
Increases ascorbic acid influence on structure and permeability of vascular wall.
The ampoule contents cannot be mixed with the solutions, containing ascorbic
acid.
APPLICATION AT PREGNANCY AND LACTATION:
Drug product is not recommended at pregnancy and lactation.
INFLUENCE ON ABILITY TO DRIVE AND OPERATE OTHER
MECHANISMS:
The product does not influence the rate of psychophysical reactions during
treatment.
PACKAGING:
10 tablets in blister.
3 blisters with leaflet in carton box.
Solution for injections in glass ampoules, 3 ml volume.
10 ampoules in strip cellular pack with leaflet, in carton box.
|